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Identity 
Other names: TIP27; ZNF802; DKFZp761K2222 
HGNC (Hugo): JAZF1 
Location: 7p15.2 
 
Metaphase FISH using as probe YAC908B12, which 
encompasses the entire JAZF1 at 7p15.2. 
DNA/RNA 
Description 
5 exons; spans 350kb. 
Transcription 
Major transcript: 2,980bp; coding sequence: 52-783. 
Protein 
Description 
243 amino acids. 
Expression 
Expressed in all the tissues tested with variable level. 
The tissues or organs that express JAZF1 include 
cerebellum, lung, thymus, liver, kidney, 




JAZF1 has three C2H2-type zinc fingers. It is mostly 
detected within the nucleus, with lesser amounts found 
in the cytoplasm. JAZF1 copurifies with chromatin, 
and presumably has DNA-binding properties. It has 
been reported to interact with TAK1 and function as a 
transcriptional repressor of the TAK1 gene. 
SNPs in intron 1 of JAZF1 has been reported to be 
associated with type 2 diabetes and body height. 
SNPs in intron 2 of JAZF1 have been reported to be 
associated with reduced prevalence of prostate cancer. 
Chimeric JAZF1-JJAZ1 protein (amino acid sequence 
of the first three exons of JAZF1 joined to sequence of 
the last 15 exons of JJAZ1) resulting from trans-
splicing of precursor mRNAs and identical to a product 
generated from the JAZF1-JJAZ1 gene fusion in 






JAZF1 has been identified at the breakpoints of a 
recurrent chromosomal translocation, the  
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t(7;17)(p15;q21), in endometrial stromal tumors 
(benign nodules and sarcomas). The translocation leads 
to a JAZF1-JJAZ1 fusion gene. This gene fusion is 
detected in about 50% of endometrial stromal sarcomas 
and most endometrial stromal nodules. 
Another common chromosomal translocation in 
endometrial stroma sarcomas, the t(6;7)(p21;p15), 
results in a JAZF1-PHF1 fusion. About 25-30% of 
endometrial stromal sarcomas are reported to contain 
this fusion. The sites of fusion within JAZF1 RNA to 
JJAZ1 and PHF1 RNA sequence are the same. Both 
JJAZ1(also called SUZ12) and PHF1 belong to the 
Polycomb group (PcG) gene family. 
Implicated in 
t(7;17)(p15;q21) / endometrial stromal 
nodule and endometrial sarcoma 
Disease 








The fusion protein protects cells from hypoxia-induced 
apoptosis, and also promotes proliferation when the 
wild-type allele of JJAZ1 is silenced (as it is in 
endometrial stromal sarcomas carrying the 
t(7;17)(p15;q21)). 
t(6;7)(p21;p15)/ endometrial stroma 
sarcoma 
Disease 












A SNIP in intron 2 of JAZF1 is associated with a 
somewhat decreased risk of prostate cancer, especially 
cancers that have been classified as being less 
aggressive. The mechanism by which polymer-phisms 
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